人工知能は炎症性腸疾患のスクリーニング効率を向上させる 臨床試験:前向きな研究
Akshita Gupta1, Ryan C Ungaro1, Adam Steinlauf1
1Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Inflammatory bowel diseases
|February 18, 2026
まとめ
大型言語モデル (LLM) を使用した新しいAIツールにより,炎症性腸疾患 (IBD) 臨床試験の募集が強化されました. AIツールは,従来の医師紹介と比較して,患者の識別とスクリーニングの効率を向上させました.
科学分野:
- * 臨床試験の募集について
- * 医療における人工知能
- * 炎症性腸疾患 (IBD) 研究について
背景:
- * 臨床試験はIBD治療の進歩に不可欠です.
- * 患者募集は,臨床試験の完了における重要なボトルネックであり続けています.
- *適格な患者を特定するための現在の方法は,非効率である可能性があります.
研究 の 目的:
- * 大型言語モデル (LLM) ベースのAIツールの有効性を評価し,IBDの臨床試験における患者識別を改善する.
- *AIツールのパフォーマンスを従来の医師紹介方法と比較するために.
- *AIが臨床試験のスクリーニング効率に与える影響を評価する.
主な方法:
- * 電子医療記録 (EMR) をスクリーニングするためのLLMベースのAIツールの開発と実装.
- *AIツールは,IBD臨床試験の特定の含有および除外基準でプログラムされました.
- * 候補患者リストは,AIツールによって生成され,評価のためにランク付けされました.
主要な成果:
- * LLMベースのAIツールは,IBD臨床試験に潜在的に適格な患者の特定を大幅に改善しました.
- *AI駆動のスクリーニングは,標準的な医師紹介と比較して,より高い効率性を示しました.
- * ランク付けされた候補者リストは,より効率的な審査プロセスを促進しました.
結論:
- * LLMベースのAIツールは,IBD臨床試験の患者募集を強化するための有望なソリューションを提供します.
- *AIはスクリーニングプロセスを最適化し,より迅速かつ効率的な試験登録につながります.
- * この技術は,IBDの研究と治療の開発を加速させる可能性を秘めています.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
940
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
940
01:29Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
607
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
607
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
962
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
962
01:21Inflammatory Bowel Disease V: Surgical Management
731
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
731